Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients

NCT01171209 is registered in ClinicalTrials.gov with Melinda Magyari as lead sponsor.

NCT NCT01171209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01171209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients
Lead sponsor
Melinda Magyari
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2010
Completion date
August 31, 2011
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis